#RadOnc Physician @KURadonc ⬅️ @MayoClinic RadOnc Residency ⬅️ @UMKCMedSchool ⬅️ #KCMO | #MedEd Illustrator | DM to collaborate
Rochester, MN
Joined June 2018
- Tweets609
- Following1K
- Followers1.5K
- Likes11.8K
Danielle A. Cunningham, MD retweeted
I recommend standard of care radiation treatment, recommended by NCCN guidelines. @UHC @evicorehc denies preauth. I call for P2P and next available slot is one week away! Progressive cancer cannot wait. I escalate request and get no call back. #fixpriorauth @RogerMarshallMD
Danielle A. Cunningham, MD retweeted
@PDBrownOnc dropping pearls of wisdom and insight!
A classic Paul Brown teaching for residents that has been ingrained.
“The greatest impacts we can make in our profession are with the patients sitting in front of us.” 🙏🏽🙏🏽🙏🏽
Danielle A. Cunningham, MD retweeted
Honored to have “Past Paste” selected for the September issue’s cover @IJROBP @sueyom @jenniferbellon2, thank you! Grateful for continued support of the #HealthHumanities @hopkinskimmel by @JHMRadOnc @ANViswanathanMD ☢️🎨✍️
Danielle A. Cunningham, MD retweeted
Congrats to Dr Akhavan! First R01 for junior faculty physician scientist @KURadonc @KUMedCenter Radiation oncologist doing cutting edge CAR T research. #wearemovingup
A $2.8M grant from @theNCI will help researchers overcome challenges in using engineered T cells to treat #glioblastoma. “Immunotherapy holds the promise of a potentially curative treatment," David Akhavan, MD, PhD, principal investigator said ➜ bit.ly/3P3xugS.
Danielle A. Cunningham, MD retweeted
Randomized Trial Vestibular Schwannoma
-No diff outcomes hearing, QOL, equilibrium between SRS or observe arm jamanetwork.com/journals/jam…
Danielle A. Cunningham, MD retweeted
Congratulations Dr. John Einck on being awarded the distinction of ASTRO Fellow (FASTRO)! ASTRO fellows are recognized for their commendable and sustained service to the field of Oncology and is earned by only a small percentage of the nearly 10,000 society members.
Danielle A. Cunningham, MD retweeted
Practice Changing Trial BRAF & MEK inhib newly diagnosed Papillary Craniopharyngiomas
· 94% response rate, vast majority durable
· Future less aggressive surgery
· ?? adjuvant vs salvage RT nejm.org/doi/full/10.1056/NE…
Danielle A. Cunningham, MD retweeted
🎉 #radonc PGY-2 Twitter Orientation Week 🎉
ACRO has even more great resources!
♠️♥️♣️♦️ACRODecks by @QatKhanMD are a great intro for 🧠 & 🫁 services with more decks to come
acro.org/page/Residents#ACRO…
Also check out our Educational Videos 🎥 for 🔥 #radonc topics
Danielle A. Cunningham, MD retweeted
Good luck to all RO residents taking boards tomorrow, you got this 👍🏻 many thanks to all the educators who created wonderful tools for review @RadOncQuestions @CunninghamOnc @ARRO_org @roecsg
Danielle A. Cunningham, MD retweeted
Privileged to be part of this work from @SWOG led by @reshmajagsi and @KalinskyKevin. 2° analysis of RxPONDER: ⬇️ LRR in biologically favorable low-burden pN+ HR+/HER2- #breastcancer patients even without regional nodal #radiotherapy. Enroll on TAILOR RT! tinyurl.com/yc5evp98
Danielle A. Cunningham, MD retweeted
Kudos to Dr. Wijnenga @MartinvdenBent & colleagues for this informative study
This work supports CNS5GBM classification
- No diff OS isolated TERTp mutation
compared to cases with additional EGFR amplification and/or 7+/10-
Danielle A. Cunningham, MD retweeted
Had a wonderful *pregame* discussion tonight. Yay! Many thanks to @AnnaLaVigneMD, @CunninghamOnc, & Will Sperduto for taking time to brainstorm excellent #HealthHumanities ideas 💡
Thanks to @SprakerMDPhD & @ParikhSimul too 😊 TAP co-hosts
So excited for the full episode!!🥰🎨
Danielle A. Cunningham, MD retweeted
Tonight, we celebrate our ⭐️outstanding⭐️ graduating 🎓residents @LindsayMorrisMD @CunninghamOnc @HunterGits. We are so so proud of all that you have done and all the patients you will help in the years to come! ❤️ Thank you for all you do!
Danielle A. Cunningham, MD retweeted
Congratulations to our graduates! So proud of the brilliant, talented, and compassionate physicians you have become! It was a privilege being a part of your journey! Cheers to @CunninghamOnc @HunterGits @LindsayMorrisMD @MayoRadOnc 🎉🎓
Tonight, we celebrate our ⭐️outstanding⭐️ graduating 🎓residents @LindsayMorrisMD @CunninghamOnc @HunterGits. We are so so proud of all that you have done and all the patients you will help in the years to come! ❤️ Thank you for all you do!
Danielle A. Cunningham, MD retweeted
I met @LindsayMorrisMD @HunterGits @CunninghamOnc when they were rotating med students and I was a brand new PGY2. Proud to have been co-residents -> APD for this class of outstanding physicians and people. Congrats & can’t wait to see what you all accomplish in the future!! 🎉
Tonight, we celebrate our ⭐️outstanding⭐️ graduating 🎓residents @LindsayMorrisMD @CunninghamOnc @HunterGits. We are so so proud of all that you have done and all the patients you will help in the years to come! ❤️ Thank you for all you do!
Danielle A. Cunningham, MD retweeted
Newly diagnosed GBM 12 cycles vs 6 cycles Temozolomide, is more better?
The answer is NO pubmed.ncbi.nlm.nih.gov/3232…
Danielle A. Cunningham, MD retweeted
With compelling evidence supporting either HA-WBRT+memantine or SRS for small cell brain mets, we have reached equipoise in our field. Our patients need our community to complete accrual to NRG CC009, SRS vs. HA-WBRT+memantine for small cell brain mets.
Danielle A. Cunningham, MD retweeted
In this JNCI CS report, AYA cancer survivors face physical and psychological sequelae decades after treatment completion, with common anxiety and depressive disorders. Preventive strategies are needed.
Read more here: bit.ly/43M5SCa
Danielle A. Cunningham, MD retweeted
In GBM is there a role for “supramaximal” resection of FLAIR/T2 tumor beyond contrast enhancing tumor?
· RANO resect group study would suggest YES
· Thought provoking study difficult to tease out inherent selection bias (favorable location, smaller tumor)
doi.org/10.1093/neuonc/noac1…
